Background Acid-fast bacilli and are the causative organisms behind two major diseases of developing nations, tuberculosis and leprosy, respectively. To efficiently tackle these diseases in developing nations, drugs must be augmented with improved detection modalities. This necessitates the development of enhanced tools that can aid the current detection modalities being used in high-incidence areas. A no-code artificial intelligence model based on image classification is one such tool that can be used in the identification of acid-fast bacilli. This study utilizes three such no-code artificial intelligence models that originate from three different platforms but share identical training, testing, and subsequent evaluation. Thereafter, the study is directed at comparing the three models created and identifying the one that can function as a promising support system for the detection of acid-fast bacilli. Methods To begin with, a total of 1000 images per class, i.e., positive and negative for each disease, were captured from the diagnosed slides of tuberculosis and leprosy, taken from the Department of Pathology. Subsequently, these slides were reviewed again by a pathologist to demarcate them as positive or negative for acid-fast bacilli. Once the required number of images was captured, 600 images of each class were selected as the training set, 300 images as the testing set, and the remaining 100 images as the evaluation set. Data augmentation was then performed using techniques such as rotating, mirroring, cropping, and position shifting. These designated data sets were then used to train the image classification software available on the following three platforms: Lobe (Microsoft Corporation, Redmond, Washington, United States), Create ML (Apple Inc., Cupertino, California, United States), Python-based open-source software (PerceptiLabs, Stockholm, Sweden). The final evaluation was based on different parameters such as sensitivity, specificity, ease of use, learning curve, technological resources required, and feasibility of implementation. All parameters put together served the purpose of comparison to identify the most promising model. Results Out of the three models tested, the one built using Lobe is the most promising in terms of the evaluation parameters considered. For tuberculosis, the sensitivity and specificity values obtained were 96% each, while for leprosy, they were 100% and 96%, respectively. Also, the model built using Lobe had a near-negligible learning curve, in addition to being the most cost-effective and feasible model to implement. Furthermore, it had a unique real-time training feature, which constantly improved the model throughout the testing period, till the final sensitivity and specificity values were achieved. Conclusions In clinical situations where a high number of cases are encountered each day, a no-code artificial intelligence model built using Lobe would get exposed to a huge database, getting trained in real time. Subsequently, such a model would reach considerable levels of sensitivity and specificity and in turn, act as a promising support system for the detection of acid-fast bacilli.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10882636 | PMC |
http://dx.doi.org/10.7759/cureus.52784 | DOI Listing |
Emerg Microbes Infect
January 2025
Key Laboratory of Jiangxi Province for Transfusion Medicine, Department of Blood Transfusion, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, China.
The tRNA-derived small RNAs (tsRNAs) are a new class of non coding RNAs, which are stable in body fluids and can be used as potential biomarkers for disease diagnosis. However, the exact value of tsRNAs in the diagnosis of tuberculosis (TB) is still unclear. The objective of the present study was to evaluate the performance of the serum tsRNAs biosignature to distinguish between active TB, healthy controls, latent TB infection, and other respiratory diseases.
View Article and Find Full Text PDFFront Cell Infect Microbiol
January 2025
Department of Tuberculosis, The Fourth People's Hospital of Nanning, Nanning, China.
Background: This study aimed to explore the accuracy of third-generation nanopore sequencing to diagnose extrapulmonary tuberculosis (EPTB).
Methods: Samples were collected from the lesions of 67 patients with suspected EPTB admitted between April 2022 and August 2023. Nanopore sequencing, acid-fast bacilli (AFB) staining, DNA testing, and X-pert and mycobacterial cultures were performed.
Lung
January 2025
Department of Medicine, National University Hospital, NUHS Tower Block, Level 10, 1E Kent Ridge Road, Singapore, 119228, Singapore.
Purpose: Tuberculosis (TB) is a highly contagious infection and one of the world's leading causes of death from a single infectious agent. Currently, TB diagnosis can be established via mycobacterial cultures, Acid Fast Bacilli smear and molecular studies. In the ever-evolving landscape of medical advancements, breath tests have shown considerable promise.
View Article and Find Full Text PDFInfect Drug Resist
January 2025
Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing, People's Republic of China.
Background: Contezolid (CZD) is an analog of Linezolid (LZD) that has demonstrated potent in vitro and in vivo activity against tuberculosis (TB) while presenting a safer side-effect profile. In this study, we evaluated the early bactericidal activity (EBA) of CZD compared to LZD, with LZD serving as a control.
Methods: Naive, smear-positive pulmonary TB patients were enrolled and randomly assigned to receive either a 14-day monotherapy regimen of 600 mg LZD once daily (QD) or 800 mg CZD twice daily (BID).
Cureus
December 2024
Department of Medicine, Medical Teaching Institution (MTI) Hayatabad Medical Complex, Peshawar, PAK.
Background Chronic diseases such as chronic kidney disease (CKD), chronic liver disease (CLD), tuberculosis (TB), dementia, and heart disease are global health concerns of significant importance, representing major causes of morbidity and mortality worldwide. Early diagnosis and interventions are critical to improve patient outcomes and reduce healthcare costs. Methods This prospective observational study analyzed clinical data from 270 patients (calculated using G*Power 3.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!